# This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)

> **NCT05608343** · PHASE3 · COMPLETED · sponsor: **Acrotech Biopharma Inc.** · enrollment: 153 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Difamilast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05608343
- **Lead sponsor:** Acrotech Biopharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-01
- **Primary completion:** 2023-10-27
- **Final completion:** 2023-10-27
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05608343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05608343, "This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05608343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*